Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01026_DB06414_nanopub.RAeKRcuGzfIgsw9hD8pPKJP49mHVo7Q19hnzIhc6fmpQI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01026_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01026_DB06414 label "DDI between Ketoconazole and Etravirine - Etravirine, when used concomitantly with Ketoconazole (and other azole derivatives), may experience an increase in serum concentration. Ketoconazole (and other azole derivatives), when used concomitantly with etravirine, may experience a decrease in serum concentration. It is recommended to monitor etravirine therapy for toxicity. [drugbank_resource:DB01026_DB06414]" assertion.
- drugbank_resource:DB01026_DB06414 identifier "drugbank_resource:DB01026_DB06414" assertion.
- drugbank_resource:DB01026_DB06414 title "DDI between Ketoconazole and Etravirine - Etravirine, when used concomitantly with Ketoconazole (and other azole derivatives), may experience an increase in serum concentration. Ketoconazole (and other azole derivatives), when used concomitantly with etravirine, may experience a decrease in serum concentration. It is recommended to monitor etravirine therapy for toxicity." assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01026_DB06414 assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01026_DB06414 assertion.